[Form 4] Synergy CHC Corp. Insider Trading Activity

Rhea-AI Filing Summary

Alfred Baumeler, who serves as President and a Director of Synergy CHC Corp. (SNYR), reported a stock option grant on 09/18/2025. The grant is for 150,000 options to purchase common stock at an exercise price of $2.38 per share. The filing lists 150,000 shares beneficially owned following the transaction and records ownership as direct. The option has an expiration date shown as 09/18/2030. The grant vests one-third on the first anniversary of the grant date and the remaining two-thirds vest in equal monthly installments over the following 24 months, subject to continued service.

Positive

• 150,000 option grant disclosed with explicit terms (exercise price and expiration) providing transparency
• Vesting schedule is specified: one‑third after one year, remainder vesting monthly over 24 months, subject to continued service
• Direct beneficial ownership of 150,000 options is reported, showing clear alignment with company equity

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Executive received a time‑based option grant that ties compensation to continued service and potential future share value.

The reported Form 4 documents a standard service‑conditioned stock option: 150,000 options at $2.38 with an explicit multi‑year vesting schedule and a 09/18/2030 expiration. From a governance perspective, the grant aligns the reporting person’s interests with long‑term shareholder value by requiring continued service to vest. The form shows direct ownership and proper Section 16 reporting protocol, signed by an attorney‑in‑fact on 09/22/2025.

Executive Compensation Analyst

TL;DR: The award is a conventional time‑vesting stock option, providing potential upside if share price rises above $2.38 before expiration.

The schedule—one‑third after one year, then monthly over 24 months—creates a three‑year full vesting horizon which is common for retention and performance alignment. Key specifics available in the filing are the grant size (150,000 options), exercise price ($2.38), transaction date (09/18/2025) and expiration (09/18/2030). No performance conditions or accelerated vesting provisions are disclosed in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baumeler Alfred

(Last) (First) (Middle)

C/O SYNERGY CHC CORP.

865 SPRING STREET

(Street)

WESTBROOK ME 04092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Synergy CHC Corp. [ SNYR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock option (right to buy)	$2.38	09/18/2025		A		150,000		(1)	09/18/2030	Common Stock, par value $0.00001 per share	150,000	$0	150,000	D

Explanation of Responses:

1. One-third (1/3) of this option grant vests on the first anniversary of the date of grant, and the remaining two-thirds (2/3) vest in equal monthly installments over the following twenty-four (24) months, subject to the reporting person's continued service with the Company.

	/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact	09/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Alfred Baumeler report on the Form 4 for SNYR?

The Form 4 reports a stock option grant of 150,000 options acquired on 09/18/2025 with an exercise price of $2.38.

What is the vesting schedule for the option grant reported by SNYR insider?

The grant vests one‑third on the first anniversary of the grant date and the remaining two‑thirds in equal monthly installments over the following 24 months, subject to continued service.

When do the options expire according to the Form 4?

The filing shows an expiration date of 09/18/2030 for the option grant.

What is the ownership form and amount after the reported transaction?

The ownership is reported as direct with 150,000 options beneficially owned following the transaction.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney‑in‑fact from Nelson Mullins Riley & Scarborough LLP on 09/22/2025.